Market Research Reports
Resources
About
Cart (0)

Contraceptives: Technologies and Global Markets

Report Code: HLC085A

Publish Date: May 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Global sales of contraceptives in 2008 were $9.9 billion and, with 2% growth, sales reached $10.1 billion in 2009.  This market is expected to rise at a CAGR of 4.8% and reach $13.5 billion by 2015.
  • The contraceptive market is led by hormonal contraceptives with more than a 78% share. This segment was worth $7.9 billion in 2009 and is expected to increase to $8.2 billion in 2010 and $9.4 billion by 2015, a compound annual growth rate of (CAGR) of 2.8%. 
  • Barrier contraceptives have a smaller market share than hormonal contraceptives but are expected to grow at a higher rate. This segment was worth $2 billion in 2009 and is expected to be valued at $2.3 billion in 2010 and $3.5 billion in 2015, an 8.5% compound annual growth rate (CAGR).

INTRODUCTION 

STUDY OBJECTIVES
 
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contraceptive products and technologies in today’s world. The key objective is to present a comprehensive analysis of the current contraceptive market and its future direction as an important method for control over child birth—and hence the population—and also as a method of protection from sexually transmitted diseases.
 
This report explores present and future strategies within the contraceptive industry, including the prevalence and market trends of the products used. The improvisation of the market, the setbacks, and the needs of the market are discussed, as well as various types of contraceptive methods, their usage and efficacy, and the technologies used in the past and present.
 
A detailed analysis of the contraceptive industry structure has been conducted, which includes the manufacturing of various types of contraceptives. Revenues are broken down by region. Sales figures are estimated for the 5–year period from 2010 through 2015. 
 
Prevalence of contraceptive methods are also discussed separately in the report, with an explanation of the decreased use in some countries. The report also covers significant patents and their allotments in each category.
 
REASONS FOR DOING THIS STUDY
 
This study was conducted to provide an update of new developments in the market of contraception technology and to provide detailed market analysis of contraceptive products along with the factors affecting this market. This industry was influenced by the economic downturn, but unlike other industries it was affected in a positive way. The advancements and the need for better and safer contraception methods have always influenced market growth. This study analyzes almost all the systems affected by these factors. 
 
Acquisition strategies and collaborations by companies are covered in this report, as well as the strength and weaknesses of each type of contraception method in light of new technologies, growing competition, and changing customer needs.
 
INTENDED AUDIENCE
 
This study contributes to the areas of market growth in contraception through contraceptive products and technologies from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest. 
 
SCOPE OF REPORT
 
The scope of this study encompasses the contraception markets. BCC analyzes each market by its prevalence, method of usage, regulatory environment, technology, market projections, and market share. Technological issues include the latest trends and developments. The study also includes women at risk and other factors influencing the market.
 
METHODOLOGY
 
Both primary and secondary research methodologies were used in this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data was collected through online research and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. 
 
INFORMATION SOURCES
 
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and suppliers of contraceptives. Data was gathered from various industry sources. BCC consulted and surveyed all the possible resources within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data was compiled from current financial, trade, and government sources.
 
ABOUT THE AUTHOR
 
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2–naphthylacetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.
  
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Contraceptives: Technologies and Global Markets146Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: OVERVIEW22Free
Chapter- 4: REGULATORY ASPECTS10Free
Chapter- 5: PREVALANCE OF CONTRACEPTIVES4Free
Chapter- 6: INDUSTRY STRUCTURE16Free
Chapter- 7: NEW DEVELOPMENTS9Free
Chapter- 8: MARKET ANALYSIS25Free
Chapter- 9: PATENT ANALYSIS21Free
Chapter- 10: MARKET TRENDS9Free
Chapter- 11: C. CRAMER & CO. GMBH23Free
Chapter- 12: APPENDIX I-ABBREVIATIONS2Free

Related Reports

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Contraceptives: Technologies and Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions